SCHEMBL2907045

SCHEMBL2907045

O=C(O)N1CCN(Cc2cn(-c3ccc(C4=COC=C(C5=CC=CCC5)O4)cc3)nc2-c2ccco2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.39
KDM4E B2RXH2 4/20 0.39
MAPT P10636 3/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 3/20 0.36
NPSR1 Q6W5P4 4/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
SSTR5 P35346 5/20 0.33
PKM P14618 2/20 0.32
HTT P42858 2/20 0.32
USP2 O75604 2/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MAPK1 P28482 2/20 0.31
HCRTR1 O43613 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2901963 0.90 ABCB1 (0.36) ALDH1A1KDM4EMAPTNPC1POLB
SCHEMBL2904995 0.89 ALDH1A1 (0.38) ALDH1A1KDM4EMAPTNPC1POLB
SCHEMBL2904799 0.88 KDM4E (0.37) ALDH1A1KDM4EMAPTNPC1POLB
SCHEMBL2909113 0.87 ALDH1A1 (0.35) ALDH1A1KDM4EMAPTNPC1POLB
SCHEMBL2901686 0.86 ALDH1A1 (0.36) ALDH1A1KDM4EMAPTNPC1POLB
SCHEMBL2908338 0.85 ALDH1A1 (0.37) ALDH1A1KDM4EMAPTNPC1POLB
SCHEMBL2908482 0.81 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTNPC1NPSR1
SCHEMBL2905281 0.78 ALDH1A1 (0.62) ALDH1A1KDM4EMAPTNPC1POLB
SCHEMBL2905976 0.78 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTNPC1POLB
SCHEMBL2904847 0.76 ALDH1A1 (0.33) ALDH1A1KDM4EMAPTNPC1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611107-B1 1,3,4-SUBSTITUTED PYRAZOLES FOR USE AS 5-HT RECEPTOR ANTAGONISTS IN THE TREATMENT OF PSYCHOSES AND NEUROLOGICAL DISORDERS MERCK PATENT GMBH (DE) 2010-08-18 EP claimed